Tag : FDA Warning
title : Major Drug Supplier Responsible For 40 Percent of Medicine Sold to U.S. Faces FDA Ban, If Sun Pharma's India Violations Aren't Fixed
summary : India’s largest drugmaker and huge supplier to the U.S. market, Sun Pharmaceutical Industries Limited, received a warning letter from U.S. Food and Drug Administration officials for violating manufacturing standards at its Halol plant in western India. Sun Pharma is estimated to supply 40 percent of the medicines sold in the United States. FDA inspectors first identified issues at the plant during September 2014.
date : Dec 20, 2015 05:43 PM EST